Sfoglia per AUTORE
ABATE A
Collezione AOU San Luigi di Orbassano
Items : 4
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma. in ESMO open / ESMO Open. 2022 Apr;7(2):100422. doi: 10.1016/j.esmoop.2022.100422. Epub 2022 Mar 7.
2022
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Laganà M; Grisanti S; Ambrosini R; Cosentini D; Abate A; Zamparini M; Ferrari VD; Gianoncelli A; Turla A; Canu L; Terzolo M; Tiberio GAM; Sigala S; Berruti A;
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells. in Cancers / Cancers (Basel). 2020 Apr 9;12(4):928. doi: 10.3390/cancers12040928.
2020
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Abate A; Rossini E; Bonini SA; Fragni M; Cosentini D; Tiberio GAM; Benetti D; Hantel C; Laganà M; Grisanti S; Terzolo M; Memo M; Berruti A; Sigala S;
Adrenocortical Carcinoma Xenograft in Zebrafish Embryos as a Model To Study the In Vivo Cytotoxicity of Abiraterone Acetate. in Endocrinology / Endocrinology. 2019 Nov 1;160(11):2620-2629. doi: 10.1210/en.2019-00152.
2019
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Gianoncelli A; Guarienti M; Fragni M; Bertuzzi M; Rossini E; Abate A; Basnet RM; Zizioli D; Bono F; Terzolo M; Memo M; Berruti A; Sigala S;
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures(?). in Molecular and cellular endocrinology / Mol Cell Endocrinol. 2019 Dec 1;498:110585. doi: 10.1016/j.mce.2019.110585. Epub 2019 Sep 16.
2019
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Fragni M; Palma Lopez LP; Rossini E; Abate A; Cosentini D; Salvi V; Vezzoli S; Poliani PL; Bosisio D; Hantel C; Tiberio GAM; Grisanti S; Memo M; Terzolo M; Berruti A; Sigala S;